Testing a new ADHD drug for children
Part of Mental health clinical trials.
This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a clear diagnosis of ADHD (not just trouble focusing).
- ADHD symptoms must be at least moderate (score of 28 or higher on a standard rating scale).
- Your child cannot have other major mental health conditions like Tourette's, panic disorder, conduct disorder, psychosis, PTSD, bipolar disorder, or severe anxiety.
- Your child cannot have autism spectrum disorder.
- Your child must not be at risk of suicide or have a substance use disorder.
- Your child's blood tests and kidney/liver function must be within safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, EB-1020, over a longer period in children with ADHD. It aims to see if the drug continues to be safe and effective beyond the initial 6-week treatment. Some participants may have already been in a previous EB-1020 study, while others are new.
This trial tests a new medication called EB-1020 for adults with ADHD. It aims to see if the drug is safe and effective in improving ADHD symptoms. You may be able to join if you have a clear ADHD diagnosis and your symptoms are moderate to severe.
This trial is for adults with ADHD who completed a previous study of the drug EB-1020. It tests the long-term safety and effectiveness of the medication over an extended period.
This trial tests starting a new medication (Methylphenidate or Guanfacine) in young children with moderate or severe ADHD to see how well it works and if it’s safe.
This trial tests if a mixed amphetamine medication helps teenagers with both autism and ADHD who still have significant symptoms, even if they are already on other treatments. It also includes typically developing teens as a comparison group.
This study tests an investigational medicine called centanafadine for adults with ADHD who also have trouble managing their emotions. The goal is to see if the medicine can help improve both attention and emotional control.
Hear when a new Attention-Deficit Hyperactivity Disorder(ADHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.